Management tracks

Swedish Orphan Biovitrum AB (SSE:SOBI) named Guido Oelkers president and CEO, effective May 22. He will replace Geoffrey McDonough. Oelkers was CEO at BSN medical GmbH, which Svenska Cellulosa AB SCA (SSE:SCAB) acquired.

Regulus Therapeutics Inc. (NASDAQ:RGLS) said President and CEO Paul Grint resigned as part of a corporate restructuring. The company promoted COO Joseph Hagan to succeed Grint. Regulus also promoted Daniel Chevallard to CFO from VP of finance and accounting...